Cargando…
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
Targeting translation initiation is an emerging anti-neoplastic strategy that capitalizes on de-regulated upstream MAPK and PI3K-mTOR signaling pathways in cancers. A key regulator of translation that controls ribosome recruitment flux is eukaryotic initiation factor (eIF) 4F, a hetero-trimeric comp...
Autores principales: | Chu, Jennifer, Galicia-Vázquez, Gabriela, Cencic, Regina, Mills, John R., Katigbak, Alexandra, Porco, John A., Pelletier, Jerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315212/ https://www.ncbi.nlm.nih.gov/pubmed/27239032 http://dx.doi.org/10.1016/j.celrep.2016.05.005 |
Ejemplares similares
-
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors
por: Katigbak, Alexandra, et al.
Publicado: (2016) -
eIF4AII is dispensable for miRNA-mediated gene silencing
por: Galicia-Vázquez, Gabriela, et al.
Publicado: (2015) -
Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F
por: Chu, Jennifer, et al.
Publicado: (2020) -
RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes
por: Robert, Francis, et al.
Publicado: (2020) -
C8ORF88: A Novel eIF4E-Binding Protein
por: Pugsley, Lauren, et al.
Publicado: (2023)